"Two years into the pandemic, the [drug] industry has evaded reforms a supermajority of voters want," begins this
New York magazine post. Big Pharma is protected partly by an "endless river
of money [that] continues to flow, the widest, steadiest current of lobbying largesse the capitol has ever known." That money only hints at "the fullness of Pharma’s influence," which the post
further details.
Read the whole story at New York Magazine »
